Covid vaccines and third dose, the Ema slows down. “At the moment it is too early to confirm if and when an” additional “booster dose for Covid-19 vaccines will be needed, because there is not yet enough data from vaccination campaigns and ongoing studies to understand how long the protection will last. vaccines, “sources from the European drug agency EMA told Adnkronos Health, after Pfizer / BioNTech announced plans to ask regulatory authorities for the green light for a third dose of Comirnaty. “The EMA – the agency assured – will rapidly examine these data as soon as they are available”.
“The EMA is working with developers of” anti-Covid “vaccines to discuss plans to produce data that can support the need for a” further “recall, and will review the information as it becomes available. to ensure that the regulatory measures necessary to allow the administration of a booster dose can be undertaken as soon as possible, should it prove necessary “.
“It seems that the 4” anti-Covid “vaccines authorized in the European Union protect against all strains of” Sars-CoV-2 virus “circulating in the EU, including the Delta variant” reported for the first time in India, which is more contagious of the others and destined to become dominant. “This highlights the importance of a complete vaccination course” concludes the EMA.